学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

松本征仁（マツモトマサヒト）

研究テーマ	細胞運命変換による難治性疾患の新たな予防・治療法の開発
研究業績（論文）	1.Yamano Y, Matsumoto M, Inoue K, Kawabata T, Morishima I: Cloning of cDNAs for Cecropins A and B, and expression of the genes in the silkworm, Bombyx mori. Biosci. Biotech. Biochem. 58: 1476-1478, 1994, IF:1.542/CI:37 2.Kawakami T, Matsumoto M, Sato M, Harada H, Taniguchi T, Kitagawa M: Possible involvement of the transcription factor ISGF3gamma in virus- induced expression of the IFN- gene. FEBS Lett. 358: 225-229, 1995, IF:3.37/CI:44 3.Kimura K, Kadokawa Y., Harada H, Matsumoto M, Sato M, Kashiwazaki Y, Tarutani T, Sok-Pin Tan R, Takasugi T, Matsuyama T, Mak TW, Noguchi S, Taniguchi T: Essential and non-redundant roles of p48 (ISGF3gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells 1: 115-124, 1996, IF:1.879/CI:187 4.Harada H, Matsumoto M, Sato M, Kashiwazaki Y, Kimura T, Kitagawa M, Yokochi T, Sok-Pin Tan R, Takasugi T, Kadokawa Y, Schindler C, Schreiber RD, Noguchi S, Taniguchi T: Regulation of IFN-alpha/beta genes：evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-gamma. Genes Cells 1: 995-1005, 1996, IF:1.879/CI:80 5.Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T, Tanaka T: Identification and characterization of nucleophosmin/B23/numatrine which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 15: 1275-1281, 1997, IF:7.971/CI:149 6.Yamano Y, Matsumoto M, Inoue K, Kawabata T, Morishima I: Structure of genes for cecropins A and inducible nuclear protein that binds to the promoter region of the genes from the silkworm, Bombyx mori. Biosci. Biotech. Biochem. 62: 237-241, 1998, IF: 1.542/CI:18 7.Matsumoto M, Tanaka N, Harada H, Kimura K., Yokochi T, Kitagawa M, Schindler C, Taniguchi T: Activation of the transcription factor ISGF3 by interferon-. Biol. Chem. 380: 699-703, 1999, IF:3.27/CI:89 8.Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto T: Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by RANKL. J. Biol. Chem. 275: 31155-31161, 2000, IF:4.238/CI:445 9.Matsumoto M, Sudo T, Maruyama M, Osada H, Tsujimoto M: Activation of p38 mitogen-acitvated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor. FEBS Lett. 486: 23-28, 2000, IF:3.37/CI:69 10.Matsumoto M, Hisatake K, Nogi Y, Tsujimoto M: Regulation of RANKL-induced TRAP gene expression by Pip/IRF-4: Synergism with MITF. J. Biol. Chem. 276: 33086-33092, 2001, IF:4.238/CI: 11.Maruyama S, Sumita K, Shen H, Kanoh M, Xu X, Sato M, Matsumoto M, Shinomiya H, Asano Y: Identification of IFN Regulatory Factor-1 Binding Site in IL-12 p40 Gene Promoter. J. Immunol. 170: 997-1001, 2003, IF:/CI: 12.Fukuda A, Tokonabe S, Hamada M, Matsumoto M, Tsukui T, Nogi Y, Hisatake K: Alleviation of PC4-mediated transcriptional repression by the ERCC3 helicase activity of general transcription factor TFIIH. J. Biol. Chem. 278: 14827-31, 2003, IF: 4.238　/CI: 13.Nakagawa K, Hisatake K, Imazawa Y, Ishiguro A, Matsumoto M, Pape L, Ishihama A., and Nogi Y: The fisson yeast RPA51 is a functional homolog of the buding yeast A49 subunit of RNA polymerase I and required for maimizing transcription of ribosomal DNA. Genes Genet. Syst. 78: 199-209, 2003, IF:/CI: 14.Fukuda A, Nakadai T, Shimada M, Tsukui T, Matsumoto M, Nogi Y, Meisternt M, Hisatake, K: A transcriptional coactivotor PC4 stimulates promoter escape and facilitates a high level of transcription activation by GAL4-VP16. Mol. Cell. Biol. 24: 6525-6535, 2004, IF:/CI: 15.Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayama S, Hisatake K, Nogi Y: Essential role of p38 MAP Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1. J. Biol. Chem. 279: 45969-45979, 2004, IF:4.238/CI: 16.Imazawa Y, Hisatake K, Mitsuzawa H, Matsumoto M, Tsukui T, Nkagawa K, Nakadai T, Shimada M, Ishihama A, Nogi Y: The fission yeast protein Ker1p is an ortholog of RNA polymerase I subunit A14 in Saccharomyces cerevisiae and is required for stable association of Rrn3p and RPA21 in RNA polymerase I. J. Biol. Chem. 280: 11467-11474, 2005, IF: 4.238　/CI:　 17.Matsumoto M. Gradual regulation of osteoclatogenesis mediated by p39 MAP kinase. Seikagaku, 79(2), 140-4, 2007 18.Hikata T, Takaishi H, Takito J, Hakozaki A, Furukawa M, Uchikawa S, Kimura T, Okada Y, Matsumoto M, Yoshimura A, Nishimura R, Reddy SV, Asahara H, Toyoma Y: PIAS3 negatively regulates the RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Blood 113: 2202-2212, 2008, IF:/CI: 19.Uemura Y, Liu TY, Narita Y, Suzuki M, Nkatsuka R, Araki T, Matsumoto M, Iwai LK, Hirasawa N, Matsuoka Y, Murakami M, Kimura T, Hase M, Kohno H, Sasaki Y, Ichihara Y, Ichihara O, Kikuchi H, Sakamoto Y, Jiao SC, Senju S, Sonoda Y: Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of V{alpha}24 invariant NKT cells. J. Immunol. 183: 201-208, 2009, IF:/CI:22 20.Huising MO, van der Meulen T, Vaughan JM, Matsumoto M, Donaldson CJ, Park H, Billestrup N, Vale WW: CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 107: 912-917, 2010, IF:/CI: 21.Huising MO, Pilbrow AP, Matsumoto M, van der Meulen T, Park H, Vaughan JM, Lee S, Vale WW: Glucocorticoids Differentially Regulate the Expression of CRFR1 and CRFR2 in MIN6 Insulinoma Cells and Rodent Islets. Endocrinology, 152: 138-150, 2011, IF:/CI: 22.Kato N, Matsumoto M, Kogawa M, Fujikawa T, Oda H, Ogata M: Critical role of p38 MAPK for regeneration of the sciatic nerve flollowing crush injury in vivo. J. NeuroInflam. 10:1 1-13, 2013, IF:5.052/CI: 23.Yamashita-Sugahara Y, Tokuzawa Y, Nakachi Y, Knesaki-Yatsuka Y, Matsumoto M, Mizuno Y, Okazaki Y: Family with sequence familarity 57, member B (Fam57b), a novel peroxisome proliferator-activated receptor g target gene that regulates adipogenesis through ceramide synthesis. J. Biol. Chem. 288: 4522-4537, 2013, IF: 4.238/CI: 24.Kogawa M, Hisatake K, Atkins GJ, Findlay DM, Enoki Y, Sato T, Gray PC, Wada S, Kato N, Fukuda A, Katayama S, Tsujimoto M, Yoda T, Suda T, Okazaki Y, Matsumoto M: The Paired-box Domain Transcription Factor Pax6 Binds to the Upstream Region of the TRAP Gene Promoter and Suppresses RANKL-induced Osteoclast Differentiation. J. Biol. Chem. 288: 31299-312, 2013, IF: 4.238/CI: 25.Matsumoto M, Kogawa M, Hisatake K, Gerald A, Findlay D, Enoki Y, Sato T, Wada S, Fukuda A, Yoda T, Suda T, Okazaki Y. Dual functions the role of Pax6 in the regulation of bone and glucose metabolism. J. Bone Miner.Res. 28, 2013. 26.Enoki Y, Sato T, Tanaka S, Iwata T, Usui M, Takeda S, Kokabu S, Matsumoto M, Okubo M, Nakashima K, Yamato M, Okano T, Fukuda T, Chida D, Imai Y, Yasuda H, Nishihara T, Akita M, Oda H, Okazaki Y, Suda T, Yoda T: Netrin-4 derived from murine vascular endothelial cells inhibits osteoclast differentiation in vitro and prevents bone loss in vivo. FEBS Lett. 588:2262-9, 2014, I 27.Blaabjerg L, Christensen GL, Matsumoto M, Huising MO, van der Meulen T, Gillestrup N, Vale W: CRFR1 activation protects against cytokine-induced beta cell death. J. Mol. Endocrinol. 53: 417-27, 2014, 28.Sugiyama T, Torio T, Sato T, Matsumoto M, Kim YT, Oda H: Involvement of skeletal fragility by teriparatide in adult osteoporosis patients: a novel mechanostat-based hypothesis for bone quality. Frontiers in Endocrinol. 6: 6, 2015, 29.Sato T, Enoki Y, Sakamoto Y, Yokota K, Okubo M, Matsumoto M, Hayashi N, Usui M, Kokabu S, Mimura T, Nakazato T, Araki N, Fukuda T, Okazaki Y, Suda T, Takeda S, Yoda T: Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase. Heliyon 1: e00013, 2015 30.Yamashita-Sugahara Y, Matsumoto M, Ohtaka M, Nishimura K, Nakanishi M, Mitani K, Okazaki Y: An inhibitor of Fibroblast Growth Factor Receptor-1 (FGFR1) promotes late-stage terminal differentiation from NGN3+ pancreatic endocrine progenitors. Scientific Rep. 6: 335908, 2016, IF:/CI:17 doi: 10.1038/srep35908 31.Jiang F-X, Li K, Archer M, Mehta M, Jamieson E, Charles A, Dickinson JE, Matsumoto M, Morahan G: Differentiation of Islet Progenitors Regulated by Nicotinamide into Transcriptome-verified β Cells that Ameliorate Diabetes. Stem Cells 35:1341-1354. 2017, IF:6.277/CI:doi: 10.1002/stem.2567 32.Sato M, Kokabu S, Enoki Y, Hayashi N, Matsumoto M, Nakahira M, Sugasawa M, Yoda T: Functional roles of netrin-1 in osteoblast differentiation. In vivo, 31(3):321-328 2017, IF: :0.953/CI: 33.Enoki Y, Sato T, Kokabu S, Hayashi N, Iwata T, Yamato M, Usui M, Matsumoto M, Tomoda T, Ariyoshi W, Nishihara T, Yoda T: Netrin-4 Promotes Differentiation and Migration of Osteoblasts. In Vivo. 31:793-799, 2017, IF:0.953/CI:0 34.Tanaka T, Kojima D, Mera T, Matsumoto M, Yasunami Y, Yanase T. Expansion of transplanted islets in mice by co-transplantation with adipose tissue-derived mesenchymal stem cells, Heliyon 17;4(5) :e00632. doi: 10.1016/j.heliyon.2018.e00632 2018, 7, IF:2.85/CI:0 35.Nakajima C, Kamimoto K, Miyajima K, Matsumoto M, Okazaki Y, Kobayashi-Hattori K, Shimizu M, Yamane T, Oishi Y, Iwatsuki K. A new method for identifying mouse pancreatic ducts. Tissue Eng. 24(8):480-485, 2018. doi: 10.1089/ten.TEC.2018.0127.2018 IF:3.5 /CI:0 36.Fink J, Matsumoto M, Tamura Y. Potential application of testosterone replacement therapy as treatment for obesity and type 2 diabetes in men. Steroids 138:161-166, 2018. doi: 10.1016/j.steroids.2018.08.002. IF:2.5 /CI:0 37.Fink J, Jackney A, Matsumoto M, Maekawa T, Nkazato K, Horie S. Performance-enhacing drugs: Procurement and administration practices of doping athletes. Phys Sportsmed. 2018 Feb;47(1):10-14. doi: 10.1080/00913847.2018.1526626. IF:1.5 /CI:0 38.Fink J, Jackney A, Matsumoto M, Maekawa T, Horie S. Mobility and biomechanical functions in the aging male: testosterone and the Locomotive Syndrome. Aging Male, 29:1-8, 2018. doi: 10.1080/13685538.2018.1504914 IF:2.0 39.Yasuoka Y, Matsumoto M, Yagi K, Okazaki Y. Evolutionary history of GLIS genes illuminates their roles in cell reprogramming and ciliogenesis. Mol. Biol. Evol., 37(1), 100-109, 2020. doi:10.1093/molbev/msz205 IF:16.24 40.Ohki J, Sakashita A, Aihara E, Inaba A, Uchiyama H, Matsumoto M, Ninomiya Y, Yamane T, Oishi Y, Iwatsuki K. Comparative analysis of enteroendocrine cells and their hormones between mouse intestinal organoids and native tissues. Biosci. Biotechnol. Biochem. 84(5), 936-42, 2020. doi:10.1080/09168451.2020.1713043 Jan/9/2020 IF=1.063 41.Tanaka A, Watanabe A, Nakano Y, Matsumoto M, Okazaki Y, Miyajima A. Reversible expansion of pancreatic islet progenitors derived from human induced pluripotent stem cells. Genes Cells 25(5), 302-311, 2020. doi: 10.1111/gtc.12759. Mar/6/2020 IF=2.326 42.Sato T, Iwata T, Usui M, Kokabu S, Sugamori Y, Takaku Y, Kobayashi T, Ito K, Matsumoto M, Takeda S, Chida D. Bone phenotype in melanocortin 2 receptor-deficient mice. Bone Rep. Aug 30; 13:100713, 2020. doi: 10.1016/j.bonr.2020.100713 IF=2.08 43.Watanabe A, Tanaka A, Koga C, Matsumoto M, Okazaki Y, Kin T, Miyajima A. CD82 is a marker to isolate β cell precursors from human iPS cells and plays a role for the maturation of β cells. Sci. Rep. 11, 9530, 2021 DOI: 10.1038/s41598-021-88978-y IF:4.576/CI:0 44.Kimura-Nakajima C, Sakaguchi K, Hatano Y, Matsumoto M, Okazaki Y, Tanaka K, Yamane T, Oishi Y, Kamimoto K, Iwatsuki K. Ngn3-positive cells arise from pancreatic duct cells. Int. J. Mol. Sci. 22(16), 8548, 2021 doi: 10.3390/ijms22168548 IF=5.923 https://doi.org/10.3390/ijms22168548

研究テーマ

細胞運命変換による難治性疾患の新たな予防・治療法の開発

研究業績（論文）

1.Yamano Y, Matsumoto M, Inoue K, Kawabata T, Morishima I: Cloning of cDNAs for Cecropins A and B, and expression of the genes in the silkworm, Bombyx mori. Biosci. Biotech. Biochem. 58: 1476-1478, 1994, IF:1.542/CI:37
2.Kawakami T, Matsumoto M, Sato M, Harada H, Taniguchi T, Kitagawa M: Possible involvement of the transcription factor ISGF3gamma in virus- induced expression of the IFN- gene. FEBS Lett. 358: 225-229, 1995, IF:3.37/CI:44
3.Kimura K, Kadokawa Y., Harada H, Matsumoto M, Sato M, Kashiwazaki Y, Tarutani T, Sok-Pin Tan R, Takasugi T, Matsuyama T, Mak TW, Noguchi S, Taniguchi T: Essential and non-redundant roles of p48 (ISGF3gamma) and IRF-1 in both type I and type II interferon responses, as revealed by gene targeting studies. Genes Cells 1: 115-124, 1996, IF:1.879/CI:187
4.Harada H, Matsumoto M, Sato M, Kashiwazaki Y, Kimura T, Kitagawa M, Yokochi T, Sok-Pin Tan R, Takasugi T, Kadokawa Y, Schindler C, Schreiber RD, Noguchi S, Taniguchi T: Regulation of IFN-alpha/beta genes：evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-gamma. Genes Cells 1: 995-1005, 1996, IF:1.879/CI:80
5.Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T, Tanaka T: Identification and characterization of nucleophosmin/B23/numatrine which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 15: 1275-1281, 1997, IF:7.971/CI:149
6.Yamano Y, Matsumoto M, Inoue K, Kawabata T, Morishima I: Structure of genes for cecropins A and inducible nuclear protein that binds to the promoter region of the genes from the silkworm, Bombyx mori. Biosci. Biotech. Biochem. 62: 237-241, 1998, IF: 1.542/CI:18
7.Matsumoto M, Tanaka N, Harada H, Kimura K., Yokochi T, Kitagawa M, Schindler C, Taniguchi T: Activation of the transcription factor ISGF3 by interferon-. Biol. Chem. 380: 699-703, 1999, IF:3.27/CI:89
8.Matsumoto M, Sudo T, Saito T, Osada H, Tsujimoto T: Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by RANKL. J. Biol. Chem. 275: 31155-31161, 2000, IF:4.238/CI:445
9.Matsumoto M, Sudo T, Maruyama M, Osada H, Tsujimoto M: Activation of p38 mitogen-acitvated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor. FEBS Lett. 486: 23-28, 2000, IF:3.37/CI:69
10.Matsumoto M, Hisatake K, Nogi Y, Tsujimoto M: Regulation of RANKL-induced TRAP gene expression by Pip/IRF-4: Synergism with MITF. J. Biol. Chem. 276: 33086-33092, 2001, IF:4.238/CI:
11.Maruyama S, Sumita K, Shen H, Kanoh M, Xu X, Sato M, Matsumoto M, Shinomiya H, Asano Y: Identification of IFN Regulatory Factor-1 Binding Site in IL-12 p40 Gene Promoter. J. Immunol. 170: 997-1001, 2003, IF:/CI:
12.Fukuda A, Tokonabe S, Hamada M, Matsumoto M, Tsukui T, Nogi Y, Hisatake K: Alleviation of PC4-mediated transcriptional repression by the ERCC3 helicase activity of general transcription factor TFIIH. J. Biol. Chem. 278: 14827-31, 2003, IF: 4.238　/CI:
13.Nakagawa K, Hisatake K, Imazawa Y, Ishiguro A, Matsumoto M, Pape L, Ishihama A., and Nogi Y: The fisson yeast RPA51 is a functional homolog of the buding yeast A49 subunit of RNA polymerase I and required for maimizing transcription of ribosomal DNA. Genes Genet. Syst. 78: 199-209, 2003, IF:/CI:
14.Fukuda A, Nakadai T, Shimada M, Tsukui T, Matsumoto M, Nogi Y, Meisternt M, Hisatake, K: A transcriptional coactivotor PC4 stimulates promoter escape and facilitates a high level of transcription activation by GAL4-VP16. Mol. Cell. Biol. 24: 6525-6535, 2004, IF:/CI:
15.Matsumoto M, Kogawa M, Wada S, Takayanagi H, Tsujimoto M, Katayama S, Hisatake K, Nogi Y: Essential role of p38 MAP Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1. J. Biol. Chem. 279: 45969-45979, 2004, IF:4.238/CI:
16.Imazawa Y, Hisatake K, Mitsuzawa H, Matsumoto M, Tsukui T, Nkagawa K, Nakadai T, Shimada M, Ishihama A, Nogi Y: The fission yeast protein Ker1p is an ortholog of RNA polymerase I subunit A14 in Saccharomyces cerevisiae and is required for stable association of Rrn3p and RPA21 in RNA polymerase I. J. Biol. Chem. 280: 11467-11474, 2005, IF: 4.238　/CI:　
17.Matsumoto M. Gradual regulation of osteoclatogenesis mediated by p39 MAP kinase. Seikagaku, 79(2), 140-4, 2007
18.Hikata T, Takaishi H, Takito J, Hakozaki A, Furukawa M, Uchikawa S, Kimura T, Okada Y, Matsumoto M, Yoshimura A, Nishimura R, Reddy SV, Asahara H, Toyoma Y: PIAS3 negatively regulates the RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts. Blood 113: 2202-2212, 2008, IF:/CI:
19.Uemura Y, Liu TY, Narita Y, Suzuki M, Nkatsuka R, Araki T, Matsumoto M, Iwai LK, Hirasawa N, Matsuoka Y, Murakami M, Kimura T, Hase M, Kohno H, Sasaki Y, Ichihara Y, Ichihara O, Kikuchi H, Sakamoto Y, Jiao SC, Senju S, Sonoda Y: Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of V{alpha}24 invariant NKT cells. J. Immunol. 183: 201-208, 2009, IF:/CI:22
20.Huising MO, van der Meulen T, Vaughan JM, Matsumoto M, Donaldson CJ, Park H, Billestrup N, Vale WW: CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 107: 912-917, 2010, IF:/CI:
21.Huising MO, Pilbrow AP, Matsumoto M, van der Meulen T, Park H, Vaughan JM, Lee S, Vale WW: Glucocorticoids Differentially Regulate the Expression of CRFR1 and CRFR2 in MIN6 Insulinoma Cells and Rodent Islets. Endocrinology, 152: 138-150, 2011, IF:/CI:
22.Kato N, Matsumoto M, Kogawa M, Fujikawa T, Oda H, Ogata M: Critical role of p38 MAPK for regeneration of the sciatic nerve flollowing crush injury in vivo. J. NeuroInflam. 10:1 1-13, 2013, IF:5.052/CI:
23.Yamashita-Sugahara Y, Tokuzawa Y, Nakachi Y, Knesaki-Yatsuka Y, Matsumoto M, Mizuno Y, Okazaki Y: Family with sequence familarity 57, member B (Fam57b), a novel peroxisome proliferator-activated receptor g target gene that regulates adipogenesis through ceramide synthesis. J. Biol. Chem. 288: 4522-4537, 2013, IF: 4.238/CI:
24.Kogawa M, Hisatake K, Atkins GJ, Findlay DM, Enoki Y, Sato T, Gray PC, Wada S, Kato N, Fukuda A, Katayama S, Tsujimoto M, Yoda T, Suda T, Okazaki Y, Matsumoto M: The Paired-box Domain Transcription Factor Pax6 Binds to the Upstream Region of the TRAP Gene Promoter and Suppresses RANKL-induced Osteoclast Differentiation. J. Biol. Chem. 288: 31299-312, 2013, IF: 4.238/CI:
25.Matsumoto M, Kogawa M, Hisatake K, Gerald A, Findlay D, Enoki Y, Sato T, Wada S, Fukuda A, Yoda T, Suda T, Okazaki Y. Dual functions the role of Pax6 in the regulation of bone and glucose metabolism. J. Bone Miner.Res. 28, 2013.
26.Enoki Y, Sato T, Tanaka S, Iwata T, Usui M, Takeda S, Kokabu S, Matsumoto M, Okubo M, Nakashima K, Yamato M, Okano T, Fukuda T, Chida D, Imai Y, Yasuda H, Nishihara T, Akita M, Oda H, Okazaki Y, Suda T, Yoda T: Netrin-4 derived from murine vascular endothelial cells inhibits osteoclast differentiation in vitro and prevents bone loss in vivo. FEBS Lett. 588:2262-9, 2014, I
27.Blaabjerg L, Christensen GL, Matsumoto M, Huising MO, van der Meulen T, Gillestrup N, Vale W: CRFR1 activation protects against cytokine-induced beta cell death. J. Mol. Endocrinol. 53: 417-27, 2014,
28.Sugiyama T, Torio T, Sato T, Matsumoto M, Kim YT, Oda H: Involvement of skeletal fragility by teriparatide in adult osteoporosis patients: a novel mechanostat-based hypothesis for bone quality. Frontiers in Endocrinol. 6: 6, 2015,
29.Sato T, Enoki Y, Sakamoto Y, Yokota K, Okubo M, Matsumoto M, Hayashi N, Usui M, Kokabu S, Mimura T, Nakazato T, Araki N, Fukuda T, Okazaki Y, Suda T, Takeda S, Yoda T: Donepezil prevents RANK-induced bone loss via inhibition of osteoclast differentiation by downregulating acetylcholinesterase. Heliyon 1: e00013, 2015
30.Yamashita-Sugahara Y, Matsumoto M, Ohtaka M, Nishimura K, Nakanishi M, Mitani K, Okazaki Y: An inhibitor of Fibroblast Growth Factor Receptor-1 (FGFR1) promotes late-stage terminal differentiation from NGN3+ pancreatic endocrine progenitors. Scientific Rep. 6: 335908, 2016, IF:/CI:17 doi: 10.1038/srep35908
31.Jiang F-X, Li K, Archer M, Mehta M, Jamieson E, Charles A, Dickinson JE, Matsumoto M, Morahan G: Differentiation of Islet Progenitors Regulated by Nicotinamide into Transcriptome-verified β Cells that Ameliorate Diabetes. Stem Cells 35:1341-1354. 2017, IF:6.277/CI:doi: 10.1002/stem.2567
32.Sato M, Kokabu S, Enoki Y, Hayashi N, Matsumoto M, Nakahira M, Sugasawa M, Yoda T: Functional roles of netrin-1 in osteoblast differentiation. In vivo, 31(3):321-328 2017, IF: :0.953/CI:
33.Enoki Y, Sato T, Kokabu S, Hayashi N, Iwata T, Yamato M, Usui M, Matsumoto M, Tomoda T, Ariyoshi W, Nishihara T, Yoda T: Netrin-4 Promotes Differentiation and Migration of Osteoblasts. In Vivo. 31:793-799, 2017, IF:0.953/CI:0
34.Tanaka T, Kojima D, Mera T, Matsumoto M, Yasunami Y, Yanase T. Expansion of transplanted islets in mice by co-transplantation with adipose tissue-derived mesenchymal stem cells, Heliyon 17;4(5) :e00632. doi: 10.1016/j.heliyon.2018.e00632 2018, 7, IF:2.85/CI:0
35.Nakajima C, Kamimoto K, Miyajima K, Matsumoto M, Okazaki Y, Kobayashi-Hattori K, Shimizu M, Yamane T, Oishi Y, Iwatsuki K. A new method for identifying mouse pancreatic ducts. Tissue Eng. 24(8):480-485, 2018. doi: 10.1089/ten.TEC.2018.0127.2018 IF:3.5 /CI:0
36.Fink J, Matsumoto M, Tamura Y. Potential application of testosterone replacement therapy as treatment for obesity and type 2 diabetes in men. Steroids 138:161-166, 2018. doi: 10.1016/j.steroids.2018.08.002. IF:2.5 /CI:0
37.Fink J, Jackney A, Matsumoto M, Maekawa T, Nkazato K, Horie S. Performance-enhacing drugs: Procurement and administration practices of doping athletes. Phys Sportsmed. 2018 Feb;47(1):10-14. doi: 10.1080/00913847.2018.1526626. IF:1.5 /CI:0
38.Fink J, Jackney A, Matsumoto M, Maekawa T, Horie S. Mobility and biomechanical functions in the aging male: testosterone and the Locomotive Syndrome. Aging Male, 29:1-8, 2018. doi: 10.1080/13685538.2018.1504914 IF:2.0
39.Yasuoka Y, Matsumoto M, Yagi K, Okazaki Y. Evolutionary history of GLIS genes illuminates their roles in cell reprogramming and ciliogenesis. Mol. Biol. Evol., 37(1), 100-109, 2020. doi:10.1093/molbev/msz205 IF:16.24
40.Ohki J, Sakashita A, Aihara E, Inaba A, Uchiyama H, Matsumoto M, Ninomiya Y, Yamane T, Oishi Y, Iwatsuki K. Comparative analysis of enteroendocrine cells and their hormones between mouse intestinal organoids and native tissues. Biosci. Biotechnol. Biochem. 84(5), 936-42, 2020. doi:10.1080/09168451.2020.1713043 Jan/9/2020 IF=1.063
41.Tanaka A, Watanabe A, Nakano Y, Matsumoto M, Okazaki Y, Miyajima A. Reversible expansion of pancreatic islet progenitors derived from human induced pluripotent stem cells. Genes Cells 25(5), 302-311, 2020. doi: 10.1111/gtc.12759. Mar/6/2020 IF=2.326
42.Sato T, Iwata T, Usui M, Kokabu S, Sugamori Y, Takaku Y, Kobayashi T, Ito K, Matsumoto M, Takeda S, Chida D. Bone phenotype in melanocortin 2 receptor-deficient mice. Bone Rep. Aug 30; 13:100713, 2020. doi: 10.1016/j.bonr.2020.100713 IF=2.08
43.Watanabe A, Tanaka A, Koga C, Matsumoto M, Okazaki Y, Kin T, Miyajima A. CD82 is a marker to isolate β cell precursors from human iPS cells and plays a role for the maturation of β cells. Sci. Rep. 11, 9530, 2021 DOI: 10.1038/s41598-021-88978-y IF:4.576/CI:0
44.Kimura-Nakajima C, Sakaguchi K, Hatano Y, Matsumoto M, Okazaki Y, Tanaka K, Yamane T, Oishi Y, Kamimoto K, Iwatsuki K. Ngn3-positive cells arise from pancreatic duct cells. Int. J. Mol. Sci. 22(16), 8548, 2021 doi: 10.3390/ijms22168548 IF=5.923 https://doi.org/10.3390/ijms22168548

研究者

教育活動

【学校法人順天堂】研究者情報データベース

研究業績詳細

松本 征仁（マツモト マサヒト）

松本征仁（マツモトマサヒト）